# Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease

> **NCT05824988** · — · RECRUITING · sponsor: **Shanghai Pulmonary Hospital, Shanghai, China** · enrollment: 100 (estimated)

## Conditions studied

- Mycobacterium Avium Complex
- Mycobacterium Avium-Intracellulare Infection
- Gram-Positive Bacterial Infections
- Mycobacterium Infections

## Interventions

- **OTHER:** Drug exposure

## Key facts

- **NCT ID:** NCT05824988
- **Lead sponsor:** Shanghai Pulmonary Hospital, Shanghai, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-14
- **Primary completion:** 2025-10
- **Final completion:** 2026-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-01-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05824988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05824988, "Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05824988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*